Chemotherapy modestly prolongs survival of patients with advanced gastric cancer, but strategies are needed to increase its efficacy. Histone deacetylase (HDAC) inhibitors modify chromatin and can block cancer cell proliferation and promote apoptosis
Post translational modification of histones and non-histone proteins by acetylation play a key role ...
Pancreatic cancer is one of the most lethal types of cancer with a 5-year survival rate of ~5%. Hist...
Abstract Background Glioblastoma (GBM) is the most common and most malignant primary brain cancer in...
Panobinostat, also known as Farydak®, LBH589, PNB, or panobinostat lactate, is a hydroxamic acid tha...
High-risk neuroblastoma remains a therapeutic challenge with a long-term survival rate of less than ...
Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histone deacetylas...
Lung cancer is the leading cause of cancer deaths in the United States. Current therapies are inade...
Advanced hepatocellular carcinoma still represents an unmet medical need that has only a limited ove...
Background: Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histon...
BACKGROUND: Histone deacetylases (HDACs) modulate chromatin and may influence the effect of DNA-dama...
Glioblastoma is the most common form of glioma, as well as the most aggressive. Patients suffering f...
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic process...
Wilms tumor (WT) is an embryonic kidney cancer, for which histone acetylation might be a therapeutic...
Epigenetic alterations of the histone acetylation play an important role in the regulation of gene e...
Work by JP is funded by a Royal Society University Research Fellowship award. Experiments carried ou...
Post translational modification of histones and non-histone proteins by acetylation play a key role ...
Pancreatic cancer is one of the most lethal types of cancer with a 5-year survival rate of ~5%. Hist...
Abstract Background Glioblastoma (GBM) is the most common and most malignant primary brain cancer in...
Panobinostat, also known as Farydak®, LBH589, PNB, or panobinostat lactate, is a hydroxamic acid tha...
High-risk neuroblastoma remains a therapeutic challenge with a long-term survival rate of less than ...
Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histone deacetylas...
Lung cancer is the leading cause of cancer deaths in the United States. Current therapies are inade...
Advanced hepatocellular carcinoma still represents an unmet medical need that has only a limited ove...
Background: Pancreatic cancer is a highly malignant disease with an extremely poor prognosis. Histon...
BACKGROUND: Histone deacetylases (HDACs) modulate chromatin and may influence the effect of DNA-dama...
Glioblastoma is the most common form of glioma, as well as the most aggressive. Patients suffering f...
Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic process...
Wilms tumor (WT) is an embryonic kidney cancer, for which histone acetylation might be a therapeutic...
Epigenetic alterations of the histone acetylation play an important role in the regulation of gene e...
Work by JP is funded by a Royal Society University Research Fellowship award. Experiments carried ou...
Post translational modification of histones and non-histone proteins by acetylation play a key role ...
Pancreatic cancer is one of the most lethal types of cancer with a 5-year survival rate of ~5%. Hist...
Abstract Background Glioblastoma (GBM) is the most common and most malignant primary brain cancer in...